Evolus Q4 GAAP operating income $4.2M; FY25 revenue $297.2M up 12%; guides 2026 rev $327-337M

Evolus, Inc.

Q4 GAAP operating income $4.2M vs loss $2.3M YoY; Non-GAAP operating income $7.1M, above guidance.
Full-year 2025 revenue $297.2M, up 12% YoY; sixth consecutive year of double-digit growth.
2026 revenue guidance $327M-$337M (10-13% growth); expects low- to mid-single-digit adjusted EBITDA margin.
Entered $30M secured revolving credit facility with Eclipse Business Capital (SOFR+4.25%, matures March 2029).
Evolysse (device from France) subject to 10% tariff; evaluating recovery; Jeuveau not impacted by tariffs.

item 1.01item 2.02item 2.03item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.